SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Hindalco Industries Q2 2027 Earnings Call Begins

Hindalco Industries' Q2 2027 earnings call has begun.

HINDALCO
SquawkNews Desk

Hindalco Industries's quarterly earnings call has just begun.Live earnings calls are not yet supported in the mobile app. To listen and follow along in real time, open TradingView website in your browser.

Related stories

Tata Steel Q2 Profit Rises 18% to Rs.3,666.41 Crore Tata Steel’s consolidated net profit rose 18% year on year to Rs.3,666.41 crore in Q2FY27, aided by strong demand and cost-saving measures, and beat Street estimates. M impact | EQUITY | Nov 07, 2026, 02:49 PM UTC Berkshire Hathaway Quarterly Net Income Falls 28% Berkshire Hathaway reported a 28% decline in quarterly net income as investment gains slumped and insurance operations posted lower profits. The company continued repurchasing its M impact | EQUITY | Nov 07, 2026, 02:17 PM UTC AvenuesAI Q2 Profit Rises 6% to ₹72 Crore; Revenue Jumps 47% AvenuesAI reported September-quarter net profit of ₹72 crore, up 6%, while revenue rose 47% year over year to ₹2,879 crore. M impact | EQUITY | Nov 07, 2026, 02:15 PM UTC Fredun Pharmaceuticals Q2 Net Profit Jumps 90% to ₹19 Crore Net profit rose from ₹10 crore a year earlier, while revenue increased 85% to ₹266 crore from ₹144 crore. The report attributes the gains to better demand. M impact | EQUITY | Nov 07, 2026, 02:15 PM UTC Strive Reports $509 Million Third-Quarter GAAP Profit Strive reported $509 million in third-quarter GAAP net income and purchased 8,136 BTC during the quarter. It bought another 15,124 BTC from October 1 through October 30. M impact | EQUITY | Nov 07, 2026, 02:06 PM UTC Karyopharm to Be Delisted From Nasdaq After Chapter 11 Filing Nasdaq notified Karyopharm Therapeutics on November 4 that it would delist the company's securities. Karyopharm will not appeal; trading is scheduled to be suspended November 11, w M impact | EQUITY | Nov 07, 2026, 02:06 PM UTC